Pro-death NMDA receptor signaling is promoted by the GluN2B C-terminus independently of Dapk1
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Aberrant NMDA receptor (NMDAR) activity contributes to several neurological disorders, but direct antagonism is poorly tolerated therapeutically. The GluN2B cytoplasmic C-terminal domain (CTD) represents an alternative therapeutic target since it potentiates excitotoxic signaling. The key GluN2B CTD-centred event in excitotoxicity is proposed to involve its phosphorylation at Ser-1303 by Dapk1, that is blocked by a neuroprotective cell-permeable peptide mimetic of the region. Contrary to this model, we find that excitotoxicity can proceed without increased Ser-1303 phosphorylation, and is unaffected by Dapk1 deficiency in vitro or following ischemia in vivo. Pharmacological analysis of the aforementioned neuroprotective peptide revealed that it acts in a sequence-independent manner as an open-channel NMDAR antagonist at or near the Mg2+ site, due to its high net positive charge. Thus, GluN2B-driven excitotoxic signaling can proceed independently of Dapk1 or altered Ser-1303 phosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568 · cited 1×
“DOI: 10.7554/eLife.17161 1 of 13 forebrain (Monyer et al., 1994; Cull-Candy et al., 2001; Traynelis et al., 2010; Paoletti, 2011; Wyllie et al., 2013).”
InfluentialNMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 2×
“Exchanging the CTD of GluN2B with that of GluN2A by targeted exon exchange reduces vul- nerability to excitotoxicity (Martel et al., 2012), without altering the proportion of NMDARs at synaptic vs. extrasynaptic sites, an important factor in excitotoxicity (Hardingham and Bading, 2010).”
BackgroundInfluentialSelf-citationProteomic analysis of NMDA receptor–adhesion protein signaling complexes
Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., & Grant, S. G. N. (2000) · Nature Neuroscience · doi:10.1038/76615 · Cited by 1,194
Self-citationRegulation of Gene Expression in Hippocampal Neurons by Distinct Calcium Signaling Pathways
Bading, H., Ginty, D. D., & Greenberg, M. E. (1993) · Science · doi:10.1126/science.8097060 · Cited by 1,157 · cited 1×
“…first placed overnight into a minimal defined medium (Baxter et al., 2011) containing 10% MEM (Invitrogen), 90% Salt-Glucose-Glycine (SGG) medium ( [Bading et al., 1993]; SGG: 114 mM NaCl, 0.219% NaHCO3, 5.292 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, 1 mM Glycine, 30 mM Glucose, 0.5 mM sodium…”
InfluentialExcitotoxicity and stroke: Identifying novel targets for neuroprotection
Lai, T. W., Zhang, S., & Wang, Y. T. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.006 · Cited by 1,106 · cited 6×
“While multiple pathways contribute to excitotoxicity (Tymianski, 2011), the mechanism by which CTD is thought to potentiate excitotoxicity is upstream of all of them (Parsons and Raymond, 2014; Tu et al., 2010; Lai et al., 2014).”
BackgroundInfluentialInteraction with the NMDA receptor locks CaMKII in an active conformation
Bayer, K.-U., De Koninck, P., Leonard, A. S., Hell, J. W., & Schulman, H. (2001) · Nature · doi:10.1038/35081080 · Cited by 732 · cited 1×
“The mechanism is centred on Ser-1303 of CTD2B, within a region of the CTD unique to GluN2B, and with which CaMKIIa is known to interact and phosphorylate (Bayer et al., 2001; Mao et al., 2014).”
BackgroundCheng, D., Hoogenraad, C. C., Rush, J., Ramm, E., Schlager, M. A., Duong, D. M., Xu, P., Wijayawardana, S. R., Hanfelt, J., Nakagawa, T., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.d500009-mcp200 · Cited by 510 · cited 2×
“…density screens (Husi et al., 2000; Collins et al., 2006; Yoshimura et al., 2004; Li et al., 2004; Jordan et al., 2004; Peng et al., 2004; Cheng et al., 2006; Bayés et al., 2011), and we failed to detect it in a recent proteomic analysis of native NMDAR supercomplexes (Frank et al.,…”
BackgroundDAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
Tu, W., Xu, X., Peng, L., Zhong, X., Zhang, W., Soundarapandian, M. M., Belal, C., Wang, M., Jia, N., Zhang, W., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.055 · Cited by 493 · cited 23×
“While multiple pathways contribute to excitotoxicity (Tymianski, 2011), the mechanism by which CTD is thought to potentiate excitotoxicity is upstream of all of them (Parsons and Raymond, 2014; Tu et al., 2010; Lai et al., 2014).”
BackgroundMethodResultInfluentialPeng, J., Kim, M. J., Cheng, D., Duong, D. M., Gygi, S. P., & Sheng, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400103200 · Cited by 473 · cited 2×
“…from proteomic post-synaptic density screens (Husi et al., 2000; Collins et al., 2006; Yoshimura et al., 2004; Li et al., 2004; Jordan et al., 2004; Peng et al., 2004; Cheng et al., 2006; Bayés et al., 2011), and we failed to detect it in a recent proteomic analysis of native NMDAR supercomplexes…”
Background
Cited by
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Targeting NMDA receptors in stroke: new hope in neuroprotection
Wu, Q. J., & Tymianski, M. (2018) · Molecular Brain · doi:10.1186/s13041-018-0357-8 · Cited by 319
Regulation of NMDA glutamate receptor functions by the GluN2 subunits
Vieira, M., Yong, X. L. H., Roche, K. W., & Anggono, V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14970 · Cited by 151
“However, a more recent study using an independently generated DAPK1 knockout mouse line fails to produce a similar protection of neuronal death following excitotoxic and ischaemic insults (McQueen et al. 2017).”
DAPK1: a Novel Pathology and Treatment Target for Alzheimer’s Disease
Xu, L.-Z., Li, B.-Q., & Jia, J.-P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1242-2 · Cited by 42
McKay, S., Ryan, T. J., McQueen, J., Indersmitten, T., Marwick, K. F. M., Hasel, P., Kopanitsa, M. V., Baxter, P. S., Martel, M.-A., Kind, P. C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.089 · Cited by 42
Self-citationSuperoxide and Non-ionotropic Signaling in Neuronal Excitotoxicity
Wang, J., & Swanson, R. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00861 · Cited by 40
“GluN2B-containing NMDA receptors are most clearly involved in excitotoxicity (Martel et al., 2012; McQueen et al., 2017), and three lines of evidence also indicate that GluN2B is likewise specifically involved in excitotoxic superoxide production.”
BackgroundGluN2B S1303 phosphorylation by CaMKII or DAPK1: No indication for involvement in ischemia or LTP
Tullis, J. E., Buonarati, O. R., Coultrap, S. J., Bourke, A. M., Tiemeier, E. L., Kennedy, M. J., Herson, P. S., & Bayer, K. U. (2021) · iScience · doi:10.1016/j.isci.2021.103214 · Cited by 13
Metadata
- Authors
- McQueen, J., Ryan, T. J., McKay, S., Marwick, K., Baxter, P., Carpanini, S. M., Wishart, T. M., Gillingwater, T. H., Manson, J. C., Wyllie, D. J. A., Grant, S. G. N., McColl, B. W., Komiyama, N. H., & Hardingham, G. E.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2017-07-21
- Volume
- 6
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W2736433134
- Cited by
- 55
- References
- 16
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.